Skip to main content

This fellowship is sponsored in collaboration with United Therapeutics and is part of the DPET fellowship program.

  • Length: Two years

This postdoctoral fellowship program provides training and experience in the conduct of clinical drug trials, participation in clinical research projects under the direction of a UNC faculty member and an industry preceptor, didactic instruction in courses that supplement training and professional interests, and exposure to ethical, legal, and regulatory issues in research involving investigational and marketed drugs. Fellows participate in clinical research studies with faculty at the UNC Eshelman School of Pharmacy during the first year of appointment, and with members of a medical affairs group (phases I–IV) at United Therapeutics in the second year.

The ideal candidate should have a PharmD and possess strong analytical skills, excellent written and verbal communication skills, good organizational abilities, and evidence of leadership and team work.

Program Description

The first year of the fellowship will be spent at the UNC Eshelman School of Pharmacy. Fellows will be mentored by UNC faculty as they participate in clinical research studies.

The second year of the fellowship will be spent working with researchers in the medical affairs group at United Therapeutics. The company is located in the Research Triangle Park, a fifteen-minute drive from the UNC campus.

The fellowship provides

  • the opportunity to develop expertise in the conduct of clinical drug trials;
  • participation in original clinical research projects under the direction of a faculty mentor and industry preceptor;
  • didactic instruction in statistics and clinical drug design that supplements training and personal interests;
  • exposure to in vitro and in vivo laboratory methods used to evaluate drug absorption, metabolism, and pharmacogenomics.

Fellows will learn to

  • apply principles and applications of pharmaceutical product development and evaluation from drug discovery and target identification, to commercialization and product launch;
  • perform strengths, weakness, opportunities, and threats (SWOT) assessment to understand unmet knowledge gaps for marketed compounds;
  • develop concept protocols to address unmet knowledge gaps for marketed compounds;
  • develop and update AMCP format dossier for healthcare payer audience;
  • develop and update medical information letters;
  • understand the principles of a compliant ‘request for information’ process;
  • understand the principles of responding to unsolicited requests for off-label information;
  • apply medical knowledge to the review of promotional materials, sales training materials and advisory board content;
  • understand the principles and regulations of marketing pharmaceuticals;
  • understand and apply principles of good publication practice (GPP);
  • develop a complaint publication plan for marketed compounds.

About United Therapeutics

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. Currently, the company’s revenue-generating products are all in the field of cardiovascular medicine. While building business value in the cardiovascular field, the company is also laying important foundations for future franchises in the treatment of cancer and infectious diseases.

To Apply

Visit for instructions on submitting an application.

Application Opens: September 1, 2022

Early Application Deadline: October 31, 2022

Final Application Deadline:  November 21, 2022

Contact for Program Information

photo Bob DupuisRobert Dupuis, PharmD, BCPS

Clinical Professor of Pharmacy and Director of Fellowship Programs
3213 Kerr Hall, CB# 7569
(919) 966-6194

United Therapeutics Preceptor

Meredith Broderick, PharmD
Director, Global Medical Affairs